PhD, Northwestern University Feinberg School of Medicine; MD, Northwestern University Feinberg School of Medicine
Neurology - Massachusetts General Hospital/Brigham and Women’s Hospital
Neuro-Oncology - Memorial Sloan Kettering Cancer Center
I am a neuro-oncologist who specializes in caring for people with primary brain tumors as well as neurologic complications of cancer. I have a special interest in glioblastoma biology and am currently conducting basic research to develop novel models of this devastating disease, with the goal of uncovering new targeted therapies to translate to the clinic.
I am humbled by the opportunity to work with patients and their families during what can be a very vulnerable time. I was drawn to the collaborative clinical environment and cutting-edge research facilities at MSK, which allow me to provide the best possible clinical care while simultaneously working towards new treatments in the laboratory.
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Maya S. Graham discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].